EyePoint, Inc.·4

Feb 18, 4:07 PM ET

Ribeiro Ramiro 4

4 · EyePoint, Inc. · Filed Feb 18, 2026

Research Summary

AI-generated summary of this filing

Updated

EyePoint (EYPT) CMO Ribeiro Ramiro Exercises Options, Sells Shares

What Happened
Ribeiro Ramiro, Chief Medical Officer of EyePoint, exercised 2,437 stock options on Feb 17, 2026 at a $8.26 strike ($20,130 total) and sold the 2,437 resulting shares the same day at $15.00 per share, generating $36,555. The filing shows the derivative (the option) was converted/terminated as part of the exercise.

Key Details

  • Transaction date: 2026-02-17; Form 4 filed 2026-02-18 (timely). Accession: 0002013623-26-000006.
  • Exercise: 2,437 shares acquired via option exercise (code M) at $8.26 per share = $20,130.
  • Sale: 2,437 shares sold (code S) at $15.00 per share = $36,555.
  • Derivative entry: 2,437 shares reported as disposed at $0 — reflects conversion/termination of the option instrument after exercise.
  • Shares owned after transaction: Not disclosed in the provided filing.
  • Footnote: The option vests 25% on Jan 3, 2026, then ratably monthly over the next three years (see F1).
  • No 10b5-1 plan, tax-withholding, or late filing noted in the filing text provided.

Context
Because the exercised shares were sold the same day, this is effectively a cashless exercise (exercise followed by immediate sale). For retail investors: the sequence is common when insiders exercise vested options and sell shares to cover the exercise cost and taxes; it documents the mechanics (option exercise + sale) but does not, by itself, reveal the insider’s view of the company’s prospects. Transaction codes: M = option exercise, S = sale.

Insider Transaction Report

Form 4
Period: 2026-02-17
Ribeiro Ramiro
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-17$8.26/sh+2,437$20,1302,437 total
  • Sale

    Common Stock

    2026-02-17$15.00/sh2,437$36,5550 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1]
    2026-02-172,43785,313 total
    Exercise: $8.26Exp: 2035-01-03Common Stock (2,437 underlying)
Footnotes (1)
  • [F1]The option to purchase will vest and become exercisable as follows: 25% at January 3, 2026 and the remainder ratably, on a monthly basis, over the remaining three years.
Signature
/s/ Ron Honig, Attorney-in-Fact|2026-02-18

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT